Corrigendum: DCBLD1 Overexpression is associated with a poor prognosis in head and neck squamous cell carcinoma

Front Immunol. 2022 Nov 25:13:1099835. doi: 10.3389/fimmu.2022.1099835. eCollection 2022.

Authors

Ling-Ling Fu^{1

2}, Ming Yan^{1

2}, Min-Xian Ma¹, Yi Luo¹, Min Shao¹, Martin Gosau², Reinhard E Friedrich², Tobias Vollkommer², Hong-Chao Feng¹, Ralf Smeets^{2

3}

Affiliations

¹ Department of Oral and Maxillofacial Surgery, Guiyang Hospital of Stomatology, Guiyang, China.
² Department of Oral and Maxillofacial Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
³ Department of Oral and Maxillofacial Surgery, Division of Regenerative Orofacial Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Abstract

[This corrects the article DOI: 10.3389/fimmu.2022.939344.].

Keywords: DCBLD1; biomarker; head and neck squamous cell carcinoma; immune infiltrates; prognosis.

Copyright © 2022 Fu, Yan, Ma, Luo, Shao, Gosau, Friedrich, Vollkommer, Feng and Smeets.

Publication types

Published Erratum